| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1208 |
| Trial ID | NCT00064103 |
| Disease | Oropharyngeal Cancer |
| Altered gene | P53 |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | INGN 201|Advexin|Ad-p53 |
| Phase | Phase1|Phase2 |
| Recruitment status | Completed |
| Title | Clinical Protocol for Wild Type p53 Gene Induction in Premalignancies of Squamous Epithelium of the Oral Cavity and Oral Pharynx Via an Adenoviral Vector |
| Year | 2003 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | NCI-2012-02541|MDA-ID-00193|P50CA097007|CDR0000306522 |
| Cohort 1 | |||||
|
|||||